When Valerie Brown’s lung cancer returned and began to spread to other parts of her body, her doctors suggested a drug that would slow the cancer’s growth.

She’d already had surgery and radiation, and eliminating the cancer was no longer an option. Most people with her type of cancer live no more than five years.

Six years later, the 62-year-old South Jersey woman is enjoying watching her 10 grandchildren grow up.

She credits Tagrisso, a drug designed to treat her specific form of cancer. It costs about $18,000 a month and has been covered by her Medicaid plan.

But Brown fears she could soon lose access to the drug.

Earlier this year, the Trump administration approved $900 billion in sweeping cuts to Medicaid, the publicly funded health program for low-income families and people with

See Full Page